PPARG and acute kidney injury: This study initially explored the relationship between rosiglitazone and the PPARγ/NLRP3 signaling pathway and the possible mechanism of action, laying a theoretical foundation for evaluating the role of NLRP3 inflammasome in CI-AKI and performing further in-depth studies on the specific mechanisms.